Ex Parte Lanza et al - Page 3




               Appeal No. 2006-1031                                                                                                    
               Application No. 09/774,278                                                                                              
                       many purposes emulsions [of] fluorochemicals with longer extended                                               
                       stability are preferred.  In order to obtain such emulsions, fluorochemical                                     
                       liquids with boiling points above 50°C are preferred, and most preferred                                        
                       are fluorochemical liquids with boiling points above about 80°C. The                                            
                       guiding determinant should be that the oil, e.g. a fluorochemical, should be                                    
                       expected to remain in a liquid phase (less than 10% gas conversion)                                             
                       under the intended conditions of thermal induction and imaging.                                                 
                       According to the specification, page 8,                                                                         
                               [r]eference to the term ‘nongaseous’ or ‘liquid’ in the context of the                                  
                       nanoparticle emulsions of the present invention is intended to mean that                                        
                       less than 10% of the interior volume of the nanoparticles is in a gas phase                                     
                       per total volume of the nanoparticles (i.e. v/v), more preferably, no more                                      
                       than about 8% (v/v), more preferably no more than about 5% (v/v), and                                           
                       most preferably, no more than than 2% (v/v) or less. . . . The nanoparticle                                     
                       emulsions of the present invention are, preferably, lipid encapsulated. In a                                    
                       specific example, the lipid encapsulated particles may be constituted by a                                      
                       perfluorocarbon emulsion, the emulsion particles having an outer coating                                        
                       of a derivatized natural or synthetic phospholipid, a fatty acid, cholesterol,                                  
                       lipid, sphingomyelin, tocopherol, glucolipid, sterylamine, cardiolipin, a lipid                                 
                       with ether or ester linked fatty acids or a polymerized lipid.                                                  
                                                                                                                                      
               102/103                                                                                                                 
                       Claims 1, 3, 7, 8, 13, 17, 18, 21, 25, 26, 31, 35, and 68-77 stand rejected under                               
               35 U.S.C. §102(e), as anticipated by θstensen.  Claims 1, 3, 7, 8, 13, 17, 18, 21, 25, 26,                              
               31, 35, and 68-77 stand rejected under 35 U.S.C. §103(a), as obvious in view of                                         
               θstensen.                                                                                                               
                       According to the examiner (Answer, page 11)                                                                     
                               Ostensen discloses methods of performing ultrasound imaging                                             
                       comprising administering a perfluorocarbon emulsion comprising                                                  
                       such perfluorocarbons as perfluoropentane, perfluorohexane, and                                                 
                       even perfluorooctane to a specific region of a patient (see abstract,                                           
                       col 8, lines 1-60). . . .                                                                                       
                               Ostensen teaches droplets that are smaller than 10 μm and                                               
                       thus meets the limitations of the instant nanoparticles, because the                                            
                                                                  3                                                                    



Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007